• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Evans Maurice E. converted options into 50,000 shares, increasing direct ownership by 80% to 112,420 units

    1/7/22 8:00:14 AM ET
    $IMAC
    Medical Specialities
    Health Care
    Get the next $IMAC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Evans Maurice E.

    (Last) (First) (Middle)
    C/O IMAC HOLDINGS, INC.
    1605 WESTGATE CIRCLE

    (Street)
    BRENTWOOD TN 37027

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    IMAC Holdings, Inc. [ IMAC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    01/01/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/01/2022 M 50,000 A (1) 112,420 D
    Common Stock 129,702 I By: ELOS Sports and Entertainment, LLC(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Unit (1) 01/01/2022 M 50,000 (3) (3) Common Stock 50,000 $0 0 D
    Explanation of Responses:
    1. Each restricted stock unit represents a contingent right to receive one share of common stock of IMAC Holdings, Inc. (the "Company").
    2. Securities held by ELOS Sports and Entertainment, LLC ("ELOS"). Mr. Evans may be deemed to beneficially own the securities held by ELOS. Mr. Evans expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
    3. On October 31, 2020, the Company granted Mr. Evans restricted stock units for 100,000 shares of the Company's common stock covering two years of service as a director, 50% vesting in four equal quarterly installments commencing on February 1, 2021, and 50% vesting on January 1, 2022, provided Mr. Evans remains a director of the Company. This Form 4 reflects the vesting of 50,000 shares of common stock on January 1, 2022.
    /s/ Maurice E. Evans 01/07/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IMAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IMAC

    DatePrice TargetRatingAnalyst
    8/19/2021$2.35 → $1.75Buy → Neutral
    National Alliance Securities
    More analyst ratings

    $IMAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    IMAC Holdings downgraded by National Alliance Securities with a new price target

    National Alliance Securities downgraded IMAC Holdings from Buy to Neutral and set a new price target of $1.75 from $2.35 previously

    8/19/21 11:40:11 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from "IMAC" to "BACK"

    BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022. "IMAC Holdings has developed a continuum of care for optimal spinal health, from the chiropractic wellness centers at the BackSpace to the IMAC Regeneration Centers' medical doctors, nurse practitioners, and physical therapists delivering advanced and innovative medical intervention," said Jeffrey Ervin, IMAC's Chief Executive Officer. "The spine is your body's central support structure and we recognize its importance for your overall health

    8/3/22 9:22:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

    BRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. "As our company continues to expand into complementary revenue streams, we believe

    7/26/22 9:15:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    The Back Company demonstrates strong Q2 growth

    The Back Space sequential quarter traffic increased over 100% BRENTWOOD, Tenn., June 30, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), today announces significant traffic growth for The Back Company. The Back Space retail chiropractic centers, located in select Walmart stores, generated over 100% visit growth compared to the first quarter. "Our team's effort is evident as we continue to improve systems to support our doctors that delivered over 6,500 visits this calendar quarter," said Jeff Ervin, Chief Executive Officer of IMAC. "The Back Space growth for the second quarter will be a springboard to material revenue during the second half of the y

    6/30/22 9:20:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Sucoff Cary was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:33 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Evans Maurice E. was granted 100,000 shares, increasing direct ownership by 89% to 212,420 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:36 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Pruitt Michael D was granted 100,000 shares and covered exercise/tax liability with 37,000 shares, increasing direct ownership by 62% to 164,250 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:38 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    SEC Filings

    View All

    SEC Form 10-Q filed by IMAC Holdings Inc.

    10-Q - IMAC Holdings, Inc. (0001729944) (Filer)

    11/14/22 5:25:58 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form EFFECT filed by IMAC Holdings Inc.

    EFFECT - IMAC Holdings, Inc. (0001729944) (Filer)

    10/14/22 12:15:29 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form S-3/A filed by IMAC Holdings Inc. (Amendment)

    S-3/A - IMAC Holdings, Inc. (0001729944) (Filer)

    10/7/22 5:01:30 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Leadership Updates

    Live Leadership Updates

    View All

    IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer

    BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces the appointment of Sheri Gardzina, CPA as its Chief Financial Officer. To date, Ms. Gardzina has served as CFO in an interim capacity. “Sheri has been an excellent addition to our management team since joining the company and we are pleased to have her as our permanent Chief Financial Officer. She brings a wealth of financial and accounting experience to the company and I am excited to continue worki

    1/7/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Financials

    Live finance-specific insights

    View All

    IMAC Holdings Reports Third Quarter 2021 Financial Results and Provides Corporate Update

    BRENTWOOD, Tenn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the third quarter ended September 30, 2021. Financial Highlights from 3Q 2021 (all comparisons are with the quarter ended September 30, 2020, unless otherwise indicated): Total revenue was $3.49 million, compared with $3.48 millionTotal patient visits at IMAC Centers were up 10% to 43,451, compared to 39,345Net loss was $1.7 million, or a loss of $0.07 per share, compared with a net

    11/10/21 4:48:15 PM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Reports Second Quarter 2021 Financial Results

    IMAC reports 36% increase in revenues and 70% increase in patient visits as it invests in value-generating assets BRENTWOOD, Tenn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the second quarter ended June 30, 2021. Financial Highlights from 2Q 2021 (all comparisons are for the quarter ended June 30, 2020, unless otherwise indicated): Total revenue was $3.4 million, compared with $2.5 million, an increase o

    8/12/21 9:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Acquires Active Medical Center in Southwestern Chicago Suburb

    Naperville, Ill. purchase to be rebranded Mike Ditka IMAC Regeneration Center BRENTWOOD, Tenn., June 25, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the Company's expansion in the Chicago market with the asset purchase of Active Medical Center's Naperville, Illinois location, effective Monday, June 28. Active Medical Center is a medical clinic that addresses a wide variety of orthopedic treatments for various conditions through a combination of medical and physical rehabilitatio

    6/25/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    1/23/23 10:00:08 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)

    SC 13G/A - IMAC Holdings, Inc. (0001729944) (Subject)

    9/9/22 4:05:20 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    5/18/22 1:40:55 PM ET
    $IMAC
    Medical Specialities
    Health Care